Bleeding Risk Prediction in Non-Valvular Atrial Fibrillation: Comparing Risk Scores in Apixaban- and Rivaroxaban-Treated Patients
Objective This study aimed to evaluate the ability of seven bleeding risk assessment tools to predict bleeding events in patients with apixaban or rivaroxaban. Methods A retrospective analysis was conducted on 313 NVAF patients (apixaban: n = 164; rivaroxaban: n = 149) with at least one year of foll...
| الحاوية / القاعدة: | Clinical and Applied Thrombosis/Hemostasis |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
SAGE Publishing
2025-10-01
|
| الوصول للمادة أونلاين: | https://doi.org/10.1177/10760296251390902 |